Post by account_disabled on Dec 26, 2023 19:10:37 GMT 10
The immune system very effectively. And recently, vaccine trials have begun in monkeys. which is expected at the end of June You should know the preliminary results. It is considered the most advanced development of a COVID-19 vaccine in Thailand. “Vaccine Research Center The Faculty of Medicine, Chulalongkorn University, is committed to developing vaccine infrastructure. and medicine for Thai society for a long time With the confidence that 'Thailand shouldn't just wait to buy. But you should also be a co-creator.' This is another milestone in being able to develop a COVID-19 vaccine to the point of testing it in monkeys, the first in Thailand.
The new technology used to develop vaccines comes from a collaboration between the Faculty of Medicine, Chulalongkorn University and a world-class university, the University of Pennsylvania, USA. and partner Telegram Number Data organizations Received a research grant from Chulalongkorn University. in collaboration with the National Vaccine Institute and the National Research Council of Thailand (NRCT) for creating innovations to take care of our Thai society,” said Prof. Dr. Kiat. As for Chulalongkorn University's policy in developing research results to meet the needs of the country, Pharm. Putthimon Sribonfa, CEO and co-founder of Naebsolute Co., Ltd., a startup company under the incubation of the CU Innovation Hub, which developed the innovation “Shield Plus Protection.
Spray is used to spray cloth masks to effectively prevent COVID-19 germs. Mentioning such innovation: Happy to be a part of making the research results of Chula professors Benefits to society at large The pride that arises is worth more than monetary rewards. “Being a startup gives us flexibility in our operations. Create efficiency in distributing innovations that help alleviate society's problems. In addition, the company also allows Chulalongkorn students to learn and do research together. It is considered to be the integration of knowledge learned with real life. and has instilled the value of caring for society in the students as well,” Dr. Phutthimon said.
The new technology used to develop vaccines comes from a collaboration between the Faculty of Medicine, Chulalongkorn University and a world-class university, the University of Pennsylvania, USA. and partner Telegram Number Data organizations Received a research grant from Chulalongkorn University. in collaboration with the National Vaccine Institute and the National Research Council of Thailand (NRCT) for creating innovations to take care of our Thai society,” said Prof. Dr. Kiat. As for Chulalongkorn University's policy in developing research results to meet the needs of the country, Pharm. Putthimon Sribonfa, CEO and co-founder of Naebsolute Co., Ltd., a startup company under the incubation of the CU Innovation Hub, which developed the innovation “Shield Plus Protection.
Spray is used to spray cloth masks to effectively prevent COVID-19 germs. Mentioning such innovation: Happy to be a part of making the research results of Chula professors Benefits to society at large The pride that arises is worth more than monetary rewards. “Being a startup gives us flexibility in our operations. Create efficiency in distributing innovations that help alleviate society's problems. In addition, the company also allows Chulalongkorn students to learn and do research together. It is considered to be the integration of knowledge learned with real life. and has instilled the value of caring for society in the students as well,” Dr. Phutthimon said.